Antidepressant dose patterns in Swedish clinical practice

International Clinical Psychopharmacology

Volumn 12, Issue 5, 1997, Pages 283-290

  Bingefors, K ^a,b   Isacson, D ^c   Von Knorring, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Antidepressants; Doses; Drug treatment; Pharmacoepidemiology; Prescribing

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; OPIPRAMOL; PAROXETINE; PROTRIPTYLINE; SERTRALINE; TRIMIPRAMINE; VENLAFAXINE;

AFFECTIVE NEUROSIS; ARTICLE; DEPRESSION; DRUG INDICATION; DRUG UTILIZATION; GENERAL PRACTITIONER; HUMAN; MENTAL DISEASE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; SWEDEN;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PSYCHIATRY; SWEDEN;

EID: 0031465827     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199709000-00005     Document Type: Article

References (28)

1. Apoteksbolaget AB (1997) Swedish Drug Statistics [in Swedish]. Apoteksbolaget AB, Stockholm.
2. Boyer W (1992) Potential indications for the selective serotonin reuptake inhibitors. International Clinical Psychopharmacology, 6 (suppl 5), 5-12.
3. Broadhead W, Larson D, Yarnall K, et al. (1991) Tricyclic antidepressant prescribing for nonpsychiatric disorders. Journal of Family Practice, 33, 24-32.
4. Dahl M-L, Bengtsson F and Sjöqvist F (1995). New antidepressive drugs - a comparison with TCA [in Swedish]. Information från Läkemedelsverket, vol 5. Medical Products Agency, Uppsala.
5. Donoghue J (1995) A comparison of prescribing patterns of selective serotonin reuptake inhibitors in the treatment of depression in the United Kingdom. Journal of Serotonin Research, 1, 47-51.
6. Donoghue J and Tylee A (1996) The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. British Journal of Psychiatry, 168, 164-168.
7. Donoghue J, Tylee A and Wildgust H (1996) Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom 1993-5. British Medical Journal, 313, 861-862.
8. Gregor KJ, Overhage JM, Coons SJ and McDonald RC (1994) Selective serotonin reuptake inhibitor dose titration in the naturalistic setting. Clinical Therapeutics, 16, 306-315.
9. Hartzema A and Christensen D (1983) Nonmedical factors associated with the prescribing volume among family practitioners in an HMO. Medical Care, 21, 990-1000.
10. Isacson D, Bingefors K, Wennberg M and Dahlström M (1993) Factors associated with high-quantity prescriptions of benzodiazepines in Sweden. Social Science and Medicine, 36, 343-351.
11. Jacobsson L, von Knorring L and Perris C (1978) A multi-aspect classification model and its use by Swedish psychiatrists [in Swedish]. Proceedings of the Swedish Psychiatric Association, Stockholm.
12. Jerling M (1995) Dosing of antidepressants - the unknown art. Journal of Clinical Psychopharmacology, 15, 435-439.
13. Katelznick DJ, Kobak KA, Jefferson JW, Greist JH and Henk HJ (1996) Prescribing patterns of antidepressant medications for depression in a HMO. Formularly, 31, 374-388.
14. Katon W, Von Korff M, Lin E, Bush T and Ormel J (1992) The adequacy and duration of antidepressant treatment in primary care. Medical Care, 30, 67-76.
15. Läkemedelsverket (1995) Pharmacotherapy for Depression [in Swedish]. Läkemedelsverket (Medical Products Agency), Uppsala.
16. Mårtensson B and Åberg-Wistedt A (1996) The use of selective serotonin reuptake inhibitors among Swedish psychiatrists. Nordic Journal of Psychiatry, 50, 443-450.
17. Paykel ES and Priest RS (1992) Recognition and management of depression in general practice: consensus statement. British Medical Journal, 305, 1198-1202.
18. Rosholm J-U (1997) Antidepressants in general practice -too much or too little? [in Danish]. Nordic Journal of Psychiatry, 51 (suppl 38), 53-56.
19. Rosholm J-U, Gram L, Damsbo N and Hallas J (1995) Antidepressant treatment in general practice - an interview study. Scandinavian Journal of Primary Health Care, 13, 281-286.
20. Rutz W, Carlsson P, von Knorring L and Wålinder J (1992) Cost-benefit analysis of an educational program for general practitioners by the Swedish Committee for the Prevention and Treatment of Depression. Acta Psychiatrica Scandinavica, 85, 457-464.
21. SAS Institute Inc. (1987) SAS/STAT Guide for Personal Computers (Version 6 Edition). SAS Institute, Cary, North Carolina, USA.
22. Schurman R, Kramer P and Mitchell J (1985) The hidden mental health network. Archives of General Psychiatry, 42, 89-94.
23. Sclar DA, Robison LM, Skaer TL, Galin RS, Legg RF, Nemel NL, Hughes TE, Buesching DP and Morgan M (1995) Antidepressant pharmacotherapy: economic evaluation of fluoxetine, paroxetine and sertraline in a health maintenance organization. Journal of International Medical Research, 23, 395-412.
24. Socialstyrelsen (1987) Classification of Diseases 1987 [in Swedish]. Liber/Allmänna förlaget, Stockholm.
25. Sturm R and Wells K (1995) How can care for depression become more cost-effective? Journal of the American Medical Association, 273, 51-58.
26. Tylee A (1996) Depression Research in European Society (DEPRES) study. International Journal of Methods in Psychiatric Research, 6, S33-S37.
27. von Knorring L and Bingefors K (1997) Resistant depression: the need for better antidepressants. In Antidepressant Therapy at the Dawn of the 3rd Millennium. Back to the Future of the Monoamine Hypothesis. Castres, France (in press).
28. Wessling A (1990) The National Prescription Survey. A Data Base for Drug Utilization Studies in Sweden - Results and Experiences from the 1970s and 1980s. PhD thesis, Karolinska Institute, Stockholm.